StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pershing Square Capital Affirms Lifting Valeant Pharma (VRX) Stake to 9.9%
November 23, 2015 5:28 PM
Pershing Square Capital Management, L.P., the investment manager for Pershing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
13Ds
Corporate News
Hedge Funds
Next Articles
Buy Valeant Pharmaceuticals (VRX) Ahead of Investor Day Catalyst - Guggenheim
November 24, 2015 8:02 AM
Pershing Square Holdings, Ltd. Increases Position In Valeant Pharmaceuticals International
November 23, 2015 5:19 PM
Ackman's Pershing Square Moves Stake in Valeant Pharma (VRX) to 9.9%
November 23, 2015 5:17 PM
Form SC 13D/A Valeant Pharmaceuticals Filed by: Pershing Square Capital Management, L.P.
November 23, 2015 5:13 PM